- ICH GCP
- US Clinical Trials Registry
- Klinisk forsøg NCT02705391
Advanced MR Imaging in Sarcoma Patients
A Pilot Study of the Utility of Perfusion MRI and MR Elastography for Surgical Planning, Radiotherapy Target Delineation, and Treatment Response Evaluation in Newly Diagnosed Ewing Sarcoma, Rhabdomyosarcoma and Soft Tissue Sarcoma Patients
We intend to investigate the clinical application of two emerging imaging modalities for which the technical capability is currently in place at Mayo Clinic. The treatment of Ewing Sarcoma (ES), Rhabdomyosarcoma (RMS) and soft tissue sarcoma (STS) patients on this study will involve multi-disciplinary contributions from nationally recognized sarcoma experts in Radiation Oncology, Radiology, Orthopedic Surgery, Pediatric Oncology, Medical Oncology and Pathology.
Patients will undergo additional magnetic resonance (MR) imaging at the same time as the standard imaging.
The ability to compare several imaging modalities within a single cohort of patients maximizes the potential of the study to impact the future management of sarcoma patients. The collaborative nature of this study, with essential contributions from many departments will undoubtedly improve the coordinated care of sarcoma patients and naturally disseminate the advanced imaging experience that is acquired.
Studieoversigt
Status
Betingelser
Undersøgelsestype
Tilmelding (Faktiske)
Kontakter og lokationer
Studiesteder
-
-
Minnesota
-
Rochester, Minnesota, Forenede Stater, 55905
- Mayo Clinic
-
-
Deltagelseskriterier
Berettigelseskriterier
Aldre berettiget til at studere
Tager imod sunde frivillige
Køn, der er berettiget til at studere
Prøveudtagningsmetode
Studiebefolkning
Beskrivelse
Inclusion Criteria:
- Age ≥ 7 years.
- Histological confirmation of newly diagnosed localized or newly diagnosed with metastatic Ewing Sarcoma, Rhabdomyosarcoma or Soft tissue Sarcoma.
- Tumors > 5 cm in diameter.
- Planning to receive RT or surgery with or without adjuvant radiotherapy (RT) at Mayo Clinic Rochester.
- Provide informed written consent if ≥ 18 years. If < 18 years, provide informed written assent and parent or legal guardian provide informed written consent.
- Patients must have measurable disease as defined in Section 11.0.
- Willingness to participate in mandatory imaging studies at Mayo Clinic Rochester.
- Baseline MRE information deemed as acceptable for assessment
- Baseline perfusion MRI deemed as acceptable for assessment
Exclusion Criteria:
- Co-morbid conditions that would result in expected survival to be less than 5 years
Studieplan
Hvordan er undersøgelsen tilrettelagt?
Design detaljer
- Observationsmodeller: Kun etui
- Tidsperspektiver: Fremadrettet
Hvad måler undersøgelsen?
Primære resultatmål
Resultatmål |
Tidsramme |
---|---|
Establish correlation between perfusion Magnetic Resonance imaging (MRI), 18F-flourodeoxyglucose (18F-FDG) PET activity, MRI contrast enhancement, Magnetic Resonance Elastography (MRE)
Tidsramme: 5 years
|
5 years
|
Establish correlation between pathologic response for ES, RMS and STS
Tidsramme: 5 years
|
5 years
|
Sekundære resultatmål
Resultatmål |
Tidsramme |
---|---|
Establish a correlation between change in perfusion and tissue stiffness with event-free survival.
Tidsramme: 5 years
|
5 years
|
Establish a correlation between change in perfusion and tissue stiffness with overall survival.
Tidsramme: 5 years
|
5 years
|
Establish a correlation between change in perfusion and tissue stiffness with local control.
Tidsramme: 5 years
|
5 years
|
Samarbejdspartnere og efterforskere
Sponsor
Efterforskere
- Ledende efterforsker: Deanna Pafundi, Ph D, Mayo Clinic
Publikationer og nyttige links
Hjælpsomme links
Datoer for undersøgelser
Studer store datoer
Studiestart (Faktiske)
Primær færdiggørelse (Faktiske)
Studieafslutning (Faktiske)
Datoer for studieregistrering
Først indsendt
Først indsendt, der opfyldte QC-kriterier
Først opslået (Skøn)
Opdateringer af undersøgelsesjournaler
Sidste opdatering sendt (Faktiske)
Sidste opdatering indsendt, der opfyldte kvalitetskontrolkriterier
Sidst verificeret
Mere information
Begreber relateret til denne undersøgelse
Yderligere relevante MeSH-vilkår
Andre undersøgelses-id-numre
- 15-005622
Disse oplysninger blev hentet direkte fra webstedet clinicaltrials.gov uden ændringer. Hvis du har nogen anmodninger om at ændre, fjerne eller opdatere dine undersøgelsesoplysninger, bedes du kontakte register@clinicaltrials.gov. Så snart en ændring er implementeret på clinicaltrials.gov, vil denne også blive opdateret automatisk på vores hjemmeside .
Kliniske forsøg med Sarkom
-
AmgenRekrutteringAvancerede solide tumorer | Kirsten Rat Sarcoma (KRAS) pG12C mutationForenede Stater, Italien, Taiwan, Spanien, Det Forenede Kongerige, Australien, Østrig, Tyskland, Belgien, Japan, Holland, Korea, Republikken, Canada
-
Institut CurieUNICANCERAfsluttetEwing Sarcoma familie af tumorerFrankrig
-
Istituto Ortopedico RizzoliRegione Emilia-RomagnaAfsluttetEwing Sarcoma familie af tumorerDet Forenede Kongerige, Italien
-
Boehringer IngelheimIkke rekrutterer endnuAvanceret blødt vævssarkom | Udifferentieret Pleomorphic Sarcoma (UPS) | Myxofibrosarkom (MFS)
-
PharmaMarAfsluttetEwings sarkom | Primitiv neuroektodermal tumor (PNET) | Askins tumor i brystvæggen | Extraosseous Ewing's Sarcoma (EOE)Frankrig, Forenede Stater, Italien
-
Oncolytics BiotechAfsluttetOsteosarkom | Leiomyosarkom | Fibrosarkom | Sarkom, synovial | Ewing Sarcoma Familie Tumorer | Ondartet fibrøst histiocytomForenede Stater
-
Institut CurieRekrutteringLeukæmi | Osteosarkom | Neuroblastom | Rhabdomyosarkom | Tumor i centralnervesystemet | Ewing Sarcoma familie af tumorerFrankrig
-
ArQule, Inc. (a wholly owned subsidiary of Merck...AfsluttetNyrecellekarcinom (RCC) | Alveolær blød delsarkom (ASPS) | Clear Cell Sarcoma (CCS)Forenede Stater, Canada, Det Forenede Kongerige
-
National Cancer Institute (NCI)Ikke rekrutterer endnuKSHV inflammatorisk cytokinsyndrom (KICS) | Kaposi Sarcoma Herpesvirus - Associated Multicentric Castleman DiseaseForenede Stater
-
Memorial Sloan Kettering Cancer CenterWashington University School of Medicine; University of California, Los... og andre samarbejdspartnereAfsluttetSarkom | Leiomyosarkom | Ondartet perifer nerveskedetumor | Ondartet fibrøst | Histiocytom/Udifferentieret Pleomorphic SarcomaForenede Stater